What Researchers Did
Researchers compared three methods to measure how quickly cells grow in 72 human brain tumour samples, also investigating if hyperbaric oxygenation affected one of these diagnostic methods.
What They Found
The study examined 72 brain tumours, including 20 metastatic carcinomas and 41 gliomas, finding that two methods, Ki-67 and BrdU labeling indices, highly correlated with tumour malignancy. Importantly, hyperbaric oxygenation applied during in vitro BrdU labeling did not significantly increase the BrdU labeling index or its penetration depth into tissue, with the exception of hematological tumours.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy, when used alongside a specific diagnostic test (BrdU labeling) for brain tumours, generally does not improve the test's ability to show cell growth or penetration into the tissue. For Canadian patients with brain tumours, this indicates that HBOT may not enhance the effectiveness of this particular diagnostic approach, which aims to help doctors plan personalized post-surgery treatments.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was conducted in vitro using tissue samples in 1991, meaning its findings on hyperbaric oxygenation's effect on cell labeling may not directly apply to living patients or current diagnostic practices.